April 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreFebruary 10, 2026
Market insights predict the global advanced wound care industry will increase from USD 11.82 billion in 2025 to USD 18.91 billion by 2035, achieving a CAGR of 4.81%. In 2024, North America led the advanced wound care market with a 46% share, while Asia Pacific is set for the fastest growth. Moist wound care dominated by product, but active wound ca...
February 10, 2026
Market insights predict the global herbal supplement for mental health industry will increase from USD 15.04 billion in 2025 to USD 29.7 billion by 2035, achieving a CAGR of 7.04%. The rising prevalence of mental disorders and the growing demand for nutraceuticals drive the global market. North America dominated the market due to the presence of ke...
February 10, 2026
According to our insight calculates, the membrane technology in the pharmaceutical market was valued at USD 2.66 billion in 2026 and is projected to reach USD 4.43 billion by 2035, growing at a CAGR of 5.85% from 2026 to 2035....
February 09, 2026
According to forecasts, the global intranasal corticosteroids market will grow from USD 7.57 billion in 2025 to USD 12.14 billion by 2035, with an expected CAGR of 4.84%. The globally rising prevalence of chronic rhinitis due to the expanding urbanization and industrialization is demanding INCs. North America dominated the market due to its fosteri...
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segments, regional distribution (NA, EU, APAC, LA, MEA), manufacturer data, competitive benchmarking, value...
February 09, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
February 09, 2026
According to our forecasts, the clinical endpoint adjudication (CEA) market was valued at USD 0.97 billion in 2025 and is projected to grow from USD 1.05 billion in 2026 to USD 2.23 billion by 2035, expanding at a CAGR of 8.66%....
February 06, 2026
According to our forecasts, the radiopharmaceutical for nuclear medicine market was valued at USD 8.43 billion in 2026 and is projected to reach USD 17.91 billion by 2035, growing at a CAGR of 8.74% during the forecast period....
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
February 04, 2026
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and increasing adoption of drugs like apixaban and rivaroxaban....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
